SCHEMBL4175656

SCHEMBL4175656

CCCCCC(C)NC(=O)c1c(F)c(F)c(F)c(F)c1F

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 8/20 0.77
TAS1R1 Q7RTX1 8/20 0.77
TAS1R2 Q8TE23 8/20 0.77
PKM P14618 1/20 0.67
SMN1; SMN2 Q16637 1/20 0.67
MLYCD O95822 2/20 0.54
ALDH1A1 P00352 1/20 0.46
HPGD P15428 1/20 0.46
HTT P42858 1/20 0.42
ADH1B P00325 1/20 0.40
ADH1C P00326 1/20 0.40
ADH1A P07327 1/20 0.40
ADH4 P08319 1/20 0.40
ADH7 P40394 1/20 0.40
RECQL P46063 1/20 0.39
CA1 P00915 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
EPHX1 P07099 1/20 0.38
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10226866 0.87 TAS1R3 (1.00) TAS1R3TAS1R1TAS1R2PKMSMN1; SMN2
SCHEMBL4166794 0.80 PKM (1.00) TAS1R3TAS1R1TAS1R2PKMSMN1; SMN2
SCHEMBL4169995 0.75 PKM (0.70) TAS1R3TAS1R1TAS1R2PKMSMN1; SMN2
SCHEMBL704752 0.73 TAS1R3 (1.00) TAS1R3TAS1R1TAS1R2PKMSMN1; SMN2
SCHEMBL9705332 0.73 ADH1B (0.50) TAS1R3TAS1R1TAS1R2MLYCDADH1B
SCHEMBL22222488 0.72 PKM (0.83) TAS1R3TAS1R1TAS1R2PKMSMN1; SMN2
SCHEMBL1388448 0.72 TAS1R3 (0.49) TAS1R3TAS1R1TAS1R2MLYCDADH1B
SCHEMBL1805743 0.72 ADH1B (0.48) TAS1R3TAS1R1TAS1R2MLYCDADH1B
SCHEMBL14370371 0.72 FAAH (0.48) TAS1R3TAS1R1TAS1R2MLYCDALDH1A1
SCHEMBL1388446 0.72 CA1 (0.52) TAS1R3TAS1R1TAS1R2MLYCDADH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090047379-A1 Benzamide Compounds Useful as High Potency Sweet Taste Enhancers DEWIS MARK L 2009-02-19 US disclosed
US-20090047379-A1 Benzamide Compounds Useful as High Potency Sweet Taste Enhancers DEWIS MARK L 2009-02-19 US disclosed
US-20090047379-A1 Benzamide Compounds Useful as High Potency Sweet Taste Enhancers DEWIS MARK L 2009-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090047379-A1 Benzamide Compounds Useful as High Potency Sweet Taste Enhancers TAS2R10, TAS2R50, TAS2R8 TAS1R3 27/4885TAS1R1 23/4885TAS1R2 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.